期刊
CHEMICAL RESEARCH IN TOXICOLOGY
卷 31, 期 3, 页码 165-167出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrestox.8b00030
关键词
-
资金
- MIP-DILI project - IMI grant [115336]
- MRC CDSS grant [G0700654]
- MRC [MR/L006758/1, G0700654] Funding Source: UKRI
- Medical Research Council [G0700654, MR/L006758/1] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish
It is unclear whether priming of naive T cells to drugs is detectable in healthy human donors expressing different human leukocyte antigen (HLA) alleles. Thus, we examined T cell priming with drugs associated with HLA risk alleles and control compounds in 14 HLA-typed donors. Nitroso sulfamethoxazole and piperacillin activated T cells from all donors, whereas responses to carbamazepine and oxypurinol were only seen in donors expressing HLA-B*15:02 and HLA-B*58:01, respectively. Weak flucloxacillin-specific T cell responses were detected in donors expressing HLA-B*57:01 and HLA-B*58:01. These data show that the priming of T cells with certain drugs is skewed toward donors expressing specific HLA alleles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据